MCRB · Seres Therapeutics, Inc.
$4.92
+0.26 (+5.47%)
At close · Aug 25
Going-concern doubt
— flagged Aug 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 5, 2026
Market Cap
$46.03M
Shares
9.94M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-08-05 | — | |
| 8-K | 2026-08-04 | 2026-07-31 | |
| 8-K | 2026-07-08 | — | |
| 8-K | 2026-07-08 | — | |
| 8-K | 2026-06-05 | 2026-06-02 | |
| 8-K | 2026-06-01 | 2026-05-30 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| DEF 14A | 2026-04-27 | 2026-06-09 | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-03-12 | — | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-02 | 2026-02-27 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-03 | 2025-09-23 | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-07-22 | 2025-07-17 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| 8-K | 2025-04-22 | 2025-04-21 | |
| 8-K | 2025-04-14 | 2025-04-10 | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2025-03-13 | — | |
| DEF 14A | 2025-03-13 | — | |
| 8-K | 2025-02-27 | 2025-02-22 | |
| 8-K | 2025-02-06 | 2025-02-04 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-10 | 2025-01-09 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | 2024-11-07 | |
| 8-K | 2024-10-01 | 2024-09-30 | |
| 8-K | 2024-09-26 | — | |
| 8-K | 2024-09-12 | — | |
| 8-K | 2024-08-15 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-06 | 2024-08-05 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-07 | 2024-05-01 | |
| 8-K | 2024-04-23 | 2024-04-19 | |
| 8-K | 2024-04-08 | 2024-04-04 | |
| DEF 14A | 2024-03-05 | — | |
| 8-K | 2024-03-05 | — | |
| 10-K | 2024-03-05 | 2023-12-31 | |
| 8-K | 2024-02-26 | 2024-02-24 |
Showing 1–50 of 113 filings
Key facts
CIK
1609809
CUSIP
81750R201
13F (30d)
35 filings
35 filers
Visit website
Investor relations